Plasmapheresis in rheumatic diseases.
Apheresis is an innovative, expensive method for treating serious complications of refractory rheumatic disease and may be useful in selected cases. Technologic improvements which will increase our ability to remove plasma fractions and/or lymphocyte subsets are the object of study and may alter the current indications for performing apheresis, as well as increasing our basic knowledge of the disease process.